An executive order signed by the Trump administration reclassifies medical cannabis as a less dangerous drug. Although this ...

Shares of cannabis companies rose after the Trump administration reclassified marijuana as a less dangerous drug. Curaleaf increased 5.8% in premarket trading after surging 26% Wednesday on a report ...

The move follows an order from Trump to expedite the FDA reviews of three psychedelic drugs intended to treat mental health ...

By Mrinalika Roy and Christy Santhosh April 23 (Reuters) - Shares of cannabis firms reversed early gains on Thursday as ...

Attempts by state lawmakers to legalize the drug for recreational use have stalled. In 2019, the state decriminalized small ...

The Department of Justice is 'delivering on President Trump’s promise' to reclassifying medical cannabis in the US ...

The Trump administration’s moves on marijuana and psychedelics signal the start of a new era in Republican drug policy. The ...

While much is still uncertain, many in the New Mexico cannabis industry are celebrating a major policy shift in how the ...

The president ordered cannabis rescheduling and faster psychedelic approvals, but at the same time escalated drug enforcement ...

A Medicare pilot program to expand access to GLP‑1 weight‑loss drugs has been postponed until at least 2027 after major insurers declined to participate, citing cost concerns. The delay leaves many ...

That means scrubbing restrictions on psychoactive potency – the drug's THC content. What's next – reinstating the benchmark ...

Acting Attorney General Todd Blanche signed an order Thursday reclassifying state-licensed marijuana as a less dangerous drug ...